MoneyWorks4Me

Granules India informs about company updates

19 Dec 2019 Evaluate

Further to letter dated December 06, 2019, Granules India has informed that, the company had conducted detailed analysis of its Metformin Hydrochloride for N-Nitrosodimethylamine (NDMA). It was concluded from the results that NDMA is absent in Metformin Hydrochloride batches produced by Granules. This was informed to the EU authorities. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1766.45
Dr. Reddys Labs. 1193.70
Cipla 1310.10
Lupin 1954.15
Zydus Lifesciences 1117.80
View more..